- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.80 Å
- Oligo State
- homo-tetramer
- Ligands
- 4 x NAD: NICOTINAMIDE-ADENINE-DINUCLEOTIDE(Non-covalent)
- 5 x XT5: 5-[(4-cyclopropyl-1,2,3-triazol-1-yl)methyl]-2-(2-methylphenoxy)phenol(Non-covalent)
XT5.2: 16 residues within 4Å:- Chain A: G.116, F.117, M.118, M.123, F.169, M.175, P.176, A.177, Y.178, M.181, A.218, M.219, I.222, Q.234, L.238
- Ligands: NAD.1
8 PLIP interactions:8 interactions with chain A- Hydrophobic interactions: A:F.169, A:A.177, A:Y.178, A:A.218, A:M.219
- Hydrogen bonds: A:Y.178, A:Y.178, A:Q.234
XT5.3: 6 residues within 4Å:- Chain A: T.37, R.63, L.66, T.216, L.217, S.220
4 PLIP interactions:4 interactions with chain A- Hydrophobic interactions: A:T.37, A:L.217
- Water bridges: A:D.38, A:D.38
XT5.8: 15 residues within 4Å:- Chain B: G.116, F.117, M.118, M.123, F.169, P.176, A.177, Y.178, M.181, K.185, A.218, M.219, V.223, L.238
- Ligands: NAD.7
9 PLIP interactions:9 interactions with chain B- Hydrophobic interactions: B:F.169, B:A.177, B:Y.178, B:A.218, B:M.219, B:V.223, B:V.223, B:L.238
- Hydrogen bonds: B:Y.178
XT5.12: 16 residues within 4Å:- Chain C: G.116, F.117, M.118, M.123, F.169, P.176, A.177, Y.178, K.185, A.218, M.219, I.222, V.223, Q.234, L.238
- Ligands: NAD.11
12 PLIP interactions:12 interactions with chain C- Hydrophobic interactions: C:A.177, C:Y.178, C:A.218, C:M.219, C:I.222, C:V.223, C:V.223, C:Q.234, C:L.238
- Hydrogen bonds: C:Y.178, C:Q.234
- pi-Stacking: C:F.169
XT5.14: 18 residues within 4Å:- Chain D: G.116, F.117, M.118, M.123, F.169, P.176, A.177, Y.178, M.181, K.185, A.218, M.219, I.222, V.223, Q.234, L.237, L.238
- Ligands: NAD.13
12 PLIP interactions:12 interactions with chain D- Hydrophobic interactions: D:A.177, D:Y.178, D:A.218, D:M.219, D:I.222, D:V.223, D:V.223, D:L.237
- Hydrogen bonds: D:Y.178, D:Y.178, D:Q.234
- pi-Stacking: D:F.169
- 6 x CL: CHLORIDE ION(Non-functional Binders)
CL.4: 4 residues within 4Å:- Chain A: G.124, I.125, N.126, G.224
Ligand excluded by PLIPCL.5: 3 residues within 4Å:- Chain A: R.215, M.252, K.253
Ligand excluded by PLIPCL.6: 4 residues within 4Å:- Chain A: R.63, L.64, R.65, L.66
Ligand excluded by PLIPCL.9: 3 residues within 4Å:- Chain B: L.81, E.82, R.97
Ligand excluded by PLIPCL.15: 4 residues within 4Å:- Chain A: P.271
- Chain D: T.256, P.257, K.260
Ligand excluded by PLIPCL.16: 2 residues within 4Å:- Chain A: R.197
- Chain D: R.245
Ligand excluded by PLIP- 1 x NA: SODIUM ION(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Spagnuolo, L.A. et al., Evaluating the Contribution of Transition-State Destabilization to Changes in the Residence Time of Triazole-Based InhA Inhibitors. J. Am. Chem. Soc. (2017)
- Release Date
- 2017-02-15
- Peptides
- Enoyl-[acyl-carrier-protein] reductase [NADH]: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
ED
G
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.80 Å
- Oligo State
- homo-tetramer
- Ligands
- 4 x NAD: NICOTINAMIDE-ADENINE-DINUCLEOTIDE(Non-covalent)
- 5 x XT5: 5-[(4-cyclopropyl-1,2,3-triazol-1-yl)methyl]-2-(2-methylphenoxy)phenol(Non-covalent)
- 6 x CL: CHLORIDE ION(Non-functional Binders)
- 1 x NA: SODIUM ION(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Spagnuolo, L.A. et al., Evaluating the Contribution of Transition-State Destabilization to Changes in the Residence Time of Triazole-Based InhA Inhibitors. J. Am. Chem. Soc. (2017)
- Release Date
- 2017-02-15
- Peptides
- Enoyl-[acyl-carrier-protein] reductase [NADH]: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
ED
G